Status | In progress |
Decision | Selected |
Process | MT |
ID number | 565 |
Provisional Schedule
Committee meeting: 2 | 16 September 2022 |
Resolution | 17 October 2022 |
Expected publication | 28 November 2022 |
Project Team
Project lead | federica Ciamponi |
Email enquiries
- If you have any queries please email MedTech@nice.org.uk
Stakeholders
External assessment group | CEDAR |
Manufacturers | Urotronic |
Others | Association of British Healthcare Industries (ABHI) |
Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM) | |
Boston Scientific | |
Department of Health and Social Care | |
Devices for Dignity | |
Greater Manchester Health & Social Care Partnership | |
Healthcare Improvement Scotland | |
HealthTech Alliance | |
Johnson & Johnson Medical Ltd | |
Medical Technology Group | |
Medicines and Healthcare Products Regulatory Agency | |
University of Manchester Wounds Research Group | |
NHS England | |
The British In Vitro Diagnostics Association (BIVDA) | |
NHS Digital |
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
14 June 2022 - 12 July 2022 | Draft guidance: 1 |
20 May 2022 | Committee meeting: 1 |
26 November 2021 | Scope published |
04 October 2021 | Stakeholder registration opens |
For further information on our processes and methods, please see our CHTE processes and methods manual